www.Medtipster.com Source: Drug Channels, 3/6/2013
Express Scripts just released the latest iteration of its long-running Drug Trend Report. This year’s report includes both Express Scripts and legacy-Medco covered lives, so it’s the most comprehensive look at pricing and utilization.
- Specialty drug trend of 18.4% dominated traditional drug trend of -1.5%.
- Drug trend for traditional drugs fell to a record-low -1.5%, due largely to the growing substitution of less-expensive generic drugs.
- Utilization increased by 0.6%, but costs decreased by 2.2%.
- Drug trend for specialty drugs was 18.4%, consistent with its high growth rate over the past six years.
- Utilization decreased by 0.4%, while costs increased by 18.7%.
- Specialty spending is concentrated in a few conditions. For traditional drugs, treatments for the top three conditions of diabetes, high blood cholesterol, and high blood pressure–accounted for 30% of total per-member, per year (PMPY) spend.
- For specialty drugs, treatments for the top three conditions–inflammatory conditions, multiple sclerosis, and cancer–accounted for 58% of total PMPY spend.
- Trend reflects two primary components
- Change in Utilization (the total quantity of drugs obtained by plan members)–Utilization varies with changes in the number of plan members on drug therapy, the degree to which plan members are adherent to their drug therapy, and a change in the average number of days of treatment.
- Change in Unit Costs–Unit costs vary with:
- 1) the rate of inflation in brand-name drugs prices,
- 2) shifts to different drug options within a therapeutic class,
- 3) a shift in mix of therapeutic classes utilized by plan members, or
- 4) the substitution of generic drugs for brand-name drugs.